Auvi Labs, Inc. — SEC Form D Filing

Auvi Labs, Inc. filed an SEC Form D on August 26, 2026, reporting $442K raised in Medical Devices.

Form D filing details

Filing
SEC Form D
Filing date
August 26, 2026
Amount reported
$442K
Industry
Medical Devices
Website
https://auvilabs.com/

What the company does

Securities: Debt. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

Hemodialysis patients experience a high rate of vascular access failure, which is a significant clinical challenge.

Solution

Auvi Labs develops a wearable ultrasound device specifically designed to detect vascular access failure.

Verdict

This cleared because the solution directly addressed a known, high-cost clinical failure point with a tangible, portable device, not because it promised a broad platform shift. Investors were implicitly betting on the company's ability to navigate medical device regulatory pathways and execute on a focused product launch within a specialized market. The limited upside came from the niche nature of the initial application, suggesting a constrained market size without clear expansion pathways beyond hemodialysis.

Source: SEC EDGAR Form D filing